Candace Bramson - Ann Arbor MI, US George Haig - Perrysburg OH, US Denis Schrier - Ann Arbor MI, US Fong Wang - Ann Arbor MI, US
International Classification:
A61K031/44 A61K031/275 A61K031/198
US Classification:
514357000, 514561000, 514523000, 514564000
Abstract:
This invention relates to certain β-amino acids that bind to the alpha-2-delta (α2δ) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.
Methods For Using Amino Acids With Affinity For The Alpha2Delta-Protein
Candace Bramson - Ann Arbor MI, US George Haig - Perrysburg OH, US Denis Schrier - Ann Arbor MI, US Fong Wang - Ann Arbor MI, US
International Classification:
A61K 31/44 A61K 31/198 A61K 31/277
US Classification:
514357000, 514561000, 514567000, 514521000
Abstract:
This invention relates to certain β-amino acids that bind to the alpha-2-delta (α2δ) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders.
Methods For Treating Relapsing Forms Of Multiple Sclerosis
- North Chicago IL, US - Wiesbaden, DE Andreas Popp - Ludwigshafen, DE Matthew R. Rosebraugh - North Chicago IL, US George M. Haig - North Chicago IL, US Shao-Lee Lin - North Chicago IL, US
International Classification:
A61K 45/06 C07K 16/22 A61P 25/00 A61P 25/28
Abstract:
Disclosed herein are anti-RGMa antibodies and methods of using these antibodies to treat multiple sclerosis, including relapsing forms of multiple sclerosis such as relapsing-remitting multiple sclerosis or relapsing-secondary progressive multiple sclerosis.
Methods For Treating Relapsing Forms Of Multiple Sclerosis
- North Chicago IL, US - Wiesbaden, DE Andreas Popp - Ludwigshafen, DE Matthew R. Rosebraugh - North Chicago IL, US George M. Haig - North Chicago IL, US Shao-Lee Lin - North Chicago IL, US
International Classification:
C07K 16/28 A61K 45/06 A61K 39/395
Abstract:
Disclosed herein are anti-RGMa antibodies and methods of using these antibodies to treat multiple sclerosis, including relapsing forms of multiple sclerosis such as relapsing-remitting multiple sclerosis or relapsing-secondary progressive multiple sclerosis.